home / stock / ettx / ettx news


ETTX News and Press, Entasis Therapeutics Holdings Inc. From 05/03/21

Stock Information

Company Name: Entasis Therapeutics Holdings Inc.
Stock Symbol: ETTX
Market: NASDAQ
Website: entasistx.com

Menu

ETTX ETTX Quote ETTX Short ETTX News ETTX Articles ETTX Message Board
Get ETTX Alerts

News, Short Squeeze, Breakout and More Instantly...

ETTX - Entasis completes initial closing of $20M private placement with Innoviva

Clinical-stage biopharmaceutical company Entasis Therapeutics Holdings (ETTX) has completed the initial closing of an ~$7.5M stock and warrant issuance to a subsidiary of Innoviva (INVA). Upon satisfaction of certain closing conditions, Innoviva will purchase the balance of the $20M...

ETTX - Entasis Therapeutics Completes Initial Closing of $20M Private Placement with Innoviva

WALTHAM, Mass., May 03, 2021 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, announced today that it has completed the initial closing of an approximat...

ETTX - Entasis Therapeutics EPS beats by $0.30

Entasis Therapeutics (ETTX): FY GAAP EPS of -$2.10 beats by $0.30.Cash, cash equivalents and short-term investments of $53.2M.Press Release For further details see: Entasis Therapeutics EPS beats by $0.30

ETTX - Entasis Therapeutics Reports Full Year 2020 Financial Results and Provides Business Update

– Phase 3 ATTACK registration trial more than three-quarters complete – – ATTACK topline data readout expected second half of 2021 – – Zoliflodacin Phase 3 trial adds clinical trial sites, continues enrollment – WALTHAM, Mass., M...

ETTX - Entasis Therapeutics Announces Sulbactam-Durlobactam Expanded Access Program for Patients in the U.S.

WALTHAM, Mass., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, announced today the availability of an expanded access program (EAP) for ...

ETTX - Entasis Therapeutics to Present at the H.C. Wainwright BioConnect 2021 Conference

WALTHAM, Mass., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced that Dr. Manos Perros, President and Chief Executive Offi...

ETTX - Good Penny Stocks To Buy Today

Penny Stocks To Watch Before Next Week Everyone looks for good penny stocks to buy . But really, what is a good penny stock to buy in the first place; what is the criterion? The fact is, that this is easier said than done, of course, and there are plenty of factors to take into ...

ETTX - Hot Penny Stocks On Robinhood To Buy Under $4 & 1 With 343% Target

Hot Penny Stocks For Your Watch List Right Now Penny stocks have become the focus of many investors over the past year. If you’re a bit new and looking to understand what penny stocks actually are, here’s a quick definition. According to the Securities & Exchange C...

ETTX - Entasis Therapeutics to Participate in A.G.P.'s Virtual Healthcare Symposium

WALTHAM, Mass., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced that members of management will participate in A.G.P....

ETTX - Entasis Therapeutics EPS beats by $0.13

Entasis Therapeutics (ETTX): Q3 GAAP EPS of -$0.37 beats by $0.13. Cash, cash equivalents and short-term investments of $61.2MPress Release For further details see: Entasis Therapeutics EPS beats by $0.13

Previous 10 Next 10